Is Elon's Empire Crumbling?
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
| Open | 189.92 | Prev Close | 189.02 |
| High | 197.06 | Low | 189.79 |
| Volume | 8,081,951 | Volume (Avg) | 6,351 |
| 52 Week High | 214.80 | 52 Week Low | 159.42 |
| Market Cap | 344.8B | PE Ratio | 92.66 |
General
| Name | Abbvie Inc |
| Ticker | ABBV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 55,000 |
About Abbvie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Highlights
| Analyst Target | 217.04 |
| Market Cap | 344,837,200,000 |
| PE Ratio | 92.66 |
| PEG Ratio | 0.43 |
| EBITDA | 27,760,001,024 |
Valuation
| Trailing PE | 92.52 |
| Forward PE | 16.42 |
| Price/Sales (Trailing 12 Mt.) | 5.91 |
| Price/Book (Most Recent Quarter) | 242.84 |
Technicals
| Beta | 0.50 |
| 52 Week High | 214.80 |
| 52 Week Low | 159.42 |
| 50 Day Average | 3.74% |
| 200 Day Average | 3.92% |
Dividend
Abbvie Inc pays out a dividend of $6.51 per share, with a dividend yield of 3.33%.
ABBV's next dividend payment will be made to shareholders on August 15, 2025.
They pay out 263.15% of their earnings out as a dividend.
Recent Dividends
| Aug 15, 2025 | $1.64 |
| May 15, 2025 | $1.64 |
| Feb 14, 2025 | $1.64 |
| Nov 15, 2024 | $1.55 |
| Aug 15, 2024 | $1.55 |
| May 15, 2024 | $1.55 |
| Feb 15, 2024 | $1.55 |
| Nov 15, 2023 | $1.48 |
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Colonel Sanders Sold KFC For $2 Million Only To See The New Owners Cash Out For $285 Million Few Years Later — Why He Then Sued Them
Harland Sanders built Kentucky Fried Chicken into a success but sold it for just $2M, feeling sidelined as it grew into a global brand. He died in 1980.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Russia insists on achieving Ukraine goals despite Trump's ultimatum
Russia is open to peace with Ukraine, but achieving its goals remains a priority, Kremlin spokesman Dmitry Peskov said Sunday, days after U.S. President to agree to a ceasefire or .
The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008
A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Drone attacks on oil fields in Iraq's Kurdish region shut down another facility
BAGHDAD (AP) — Drones targeted Wednesday, the latest in a series of attacks in recent days that have put several oil facilities out of commission.
How Trump could use a building renovation to oust the Fed chair
WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue
WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.
Trump orders a 35% tariff for goods from Canada, citing a lack of cooperation on illicit drugs
WASHINGTON (AP) — U.S. President Donald Trump has raised the tariff rate on to 35% from 25%, effective Friday.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Semiconductor Stocks React To Key Policies And Earnings
Semiconductor chip companies, including Nvidia, AMD, Broadcom, Marvell Tech, and Super Micro had a volatile week due to trade policies and earnings.
Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow
Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Ozempic, Mounjaro Users Cut $6.5 Billion From Grocery Bills: GLP-1 Boom Triggers Panic In Packaged Food Aisles
GLP-1 medications are delivering a $6.5 billion blow to U.S. grocery spending, with weight-loss drugs altering consumer purchasing patterns.
Trump-Backed Crypto Bills Stalled Again In House Of Representatives, Marjorie Taylor Greene Holds Out On CBDC Ban: 'Will Not Vote For This'
House Republican leaders faced another setback Wednesday in their efforts to move key cryptocurrency bills, due to disagreements among GOP lawmakers.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Elon Musk's xAI Plans To Raise $12 Billion In Debt To Buy Nvidia Chips And Build One Of The World's Largest AI Superclusters: Report
Elon Musk's xAI is reportedly seeking $12 billion in debt financing to buy Nvidia chips and build a massive AI supercluster, signaling an aggressive push to stay competitive in the global AI arms race.
Is Costco Stock Topping Out? Key Price Levels To Watch
Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.
What's Going On With Advanced Micro Devices Shares Today?
Advanced Micro Devices Inc. (NASDAQ: AMD) shares are trading higher Tuesday extending momentum from Monday after reports revealed the company raised the price of its MI350 artificial intelligence chip.
Peter Thiel Effect? Cathie Wood Pours $175 Million Into Bitmine Immersion Stock As Founders Fund Backing, Ethereum Spike Fuels Buzz
Ark Invest, led by Cathie Wood, made significant trades on Monday.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
US Dollar Can Lose Its 'Supremacy Premium' If Fed Interferes With Bond Market: Currencies Are 'Release Valve For Unsustainable Fiscal Policy'
The U.S. dollar's status as the premier currency could be at risk if the Federal Reserve intervenes in the bond markets.
Spotify's Subscriber Boom Can't Hide Ad Woes: Analyst
Spotify's Q2 results missed expectations, causing analysts to lower ratings & price targets. Despite shortfalls, long-term potential remains.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Elon Musk Changed His Number, Became Unreachable After Trump Feud, Reveals Speaker Mike Johnson: 'I Sent Him A Long Text Message, And Then...'
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk has reportedly changed his phone number following a fued with President Donald Trump and disagreement with Speaker Mike Johnson over the Republican's tax-and-spending bill.
Elizabeth Warren Sounds Alarm on Tariffs: 'The Impact of Six Months of Donald Trump Will Be Felt for Two Generations'
Sen. Elizabeth Warren has voiced concern over the long-term impact of President Trump's tariffs.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Circle CEO: Stablecoins Are Going Mainstream — Fast
Jeremy Allaire, CEO of Circle Internet Group, Inc. (NYSE:CRCL), is offering a compelling vision for the future of digital finance and the role of stablecoins in the global economy.
Elon Musk's SpaceX Moves Its Bitcoin For First Time In 3 Years, Analytics Firm Notes Over $150 Million Worth Of Coins Moved To Fresh Address
A wallet associated with space technology company SpaceX transferred over $150 million in Bitcoin (CRYPTO: BTC) Tuesday, marking its first on-chain activity in over three years.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
US-EU trade deal wards off further escalation but will raise costs for companies, consumers
FRANKFURT, Germany (AP) — and European Commission President Ursula von der Leyen have that imposes 15% tariffs on most European goods, warding off Trump's threat of a 30% rate if no deal had been reached by Aug. 1.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Why Spotify's Latest Results Look Worse Than They Are
Spotify (SPOT) stock drops after missing earnings and revenue expectations, despite strong user growth. Analysts maintain Overweight and Buy ratings.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.